CXCL10 and esophageal squamous cell carcinoma: Poly(I:C), a TLR3 agonist, induced strong expression of CXCL10 mRNA and protein, which significantly enhanced caspase3/7 activity, indicating upregulation of apoptotic activity, and suppressed cell proliferation in both ESCC lines but not the EAC line.